A carregar...
Nutlin‐3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation
Adrenocortical carcinoma (ACC) is a rare malignancy, and CTNNB1 is frequently mutated in ACC. Our study aims to screen for effective agents with antineoplastic activity against ACC with CTNNB1 mutation. In‐silico screening of the Genomics of Drug Sensitivity in Cancer (GDSC) database was conducted....
Na minha lista:
| Publicado no: | Cancer Med |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5911589/ https://ncbi.nlm.nih.gov/pubmed/29532999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1431 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|